Dr. Agrawals Eye Hospital Intrinsic Value
DRAGARWQ Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1606.80 | ₹1285.44 - ₹1928.16 | -68.5% | EPS: ₹133.90, Sector P/E: 12x |
| Book Value Method | asset | ₹1019.65 | ₹917.68 - ₹1121.62 | -80.0% | Book Value/Share: ₹420.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1529.47 | ₹1376.52 - ₹1682.42 | -70.0% | Revenue/Share: ₹866.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹2039.30 | ₹1835.37 - ₹2243.23 | -60.0% | EBITDA: ₹138.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹2580.83 | ₹2064.66 - ₹3097.00 | -49.4% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹2142.40 | ₹1928.16 - ₹2356.64 | -58.0% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹1529.47 | ₹1376.52 - ₹1682.42 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹2549.12 | ₹2294.21 - ₹2804.03 | -50.0% | ROE: 30.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1529.47 | ₹1376.52 - ₹1682.42 | -70.0% | EPS: ₹133.90, BVPS: ₹420.00 |
Want to compare with current market value? Check DRAGARWQ share price latest .
Valuation Comparison Chart
DRAGARWQ Intrinsic Value Analysis
What is the intrinsic value of DRAGARWQ?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Dr. Agrawals Eye Hospital (DRAGARWQ) is ₹1606.80 (median value). With the current market price of ₹5098.25, this represents a -68.5% variance from our estimated fair value.
The valuation range spans from ₹1019.65 to ₹2580.83, indicating ₹1019.65 - ₹2580.83.
Is DRAGARWQ undervalued or overvalued?
Based on our multi-method analysis, Dr. Agrawals Eye Hospital (DRAGARWQ) appears to be trading above calculated value by approximately 68.5%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.18 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.92 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 30.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 31.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.71x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Dr. Agrawals Eye Hospital
Additional stock information and data for DRAGARWQ
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹95 Cr | ₹29 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹90 Cr | ₹55 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹70 Cr | ₹35 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹57 Cr | ₹34 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹34 Cr | ₹29 Cr | Positive Free Cash Flow | 8/10 |